SCHEMBL257340

SCHEMBL257340

CCOC(=O)c1sc(C(=O)c2ccccc2)nc1C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.59
RAB9A P51151 5/20 0.59
MAPT P10636 3/20 0.59
HPGD P15428 3/20 0.59
LMNA P02545 2/20 0.57
KMT2A Q03164 4/20 0.56
MEN1 O00255 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
CSNK1D P48730 2/20 0.56
PKM P14618 1/20 0.56
KCNH2 Q12809 1/20 0.56
CYP2C9 P11712 1/20 0.54
ALDH1A1 P00352 4/20 0.52
KDM4E B2RXH2 3/20 0.52
APOBEC3G Q9HC16 1/20 0.52
CDC7 O00311 2/20 0.51
DBF4 Q9UBU7 2/20 0.51
TRPM8 Q7Z2W7 1/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL257344 0.82 SMN1; SMN2 (0.57) NPC1RAB9AMAPTHPGDKMT2A
SCHEMBL8867673 0.82 CDC7 (0.67) NPC1RAB9AMAPTHPGDLMNA
SCHEMBL15197079 0.81 ALDH1A1 (0.52) NPC1RAB9AMAPTLMNAKMT2A
SCHEMBL25297796 0.81 ALDH1A1 (0.56) NPC1RAB9AMAPTHPGDLMNA
SCHEMBL3584407 0.77 SMN1; SMN2 (0.80) NPC1RAB9AMAPTHPGDLMNA
SCHEMBL27848208 0.77 ALDH1A1 (0.60) NPC1RAB9AMAPTHPGDLMNA
SCHEMBL1316281 0.77 CDC7 (0.77) NPC1RAB9AMAPTHPGDLMNA
SCHEMBL11098717 0.75 ALDH1A1 (0.51) NPC1RAB9AMAPTHPGDLMNA
SCHEMBL2885006 0.75 NPC1 (0.59) NPC1RAB9AMAPTHPGDLMNA
SCHEMBL289229 0.75 CDC7 (0.73) NPC1RAB9AMAPTHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 NPC1 1990/4885RAB9A 361/4885MAPT 3973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.